Outcomes in patients (pts) aged ≥ 65 years in the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC) Meeting Abstract
| Authors: | Hegewisch-Becker, S.; Oliveira, M.; Traina, T.; Tolaney, S. M.; Loirat, D.; Punie, K.; Hurvitz, S. A.; Lynce, F.; Hamilton, E.; Nanda, R.; Hart, L.; Richards, P.; Malik, Z.; Rugo, H. S.; Diéras, V.; Bardia, A.; Hong, Q.; Phan, S.; Itri, L. M.; Loibl, S.; Kalinsky, K. |
| Abstract Title: | Outcomes in patients (pts) aged ≥ 65 years in the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC) |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (Hybrid-Kongress) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 44 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2021 Oct 01-04 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2021-09-01 |
| Start Page: | 242 |
| Language: | English |
| ACCESSION: | WOS:000760622600447 |
| PROVIDER: | wos |
| DOI: | 10.1159/000518417 |
| Notes: | Meeting Abstract: ep431 "Joint Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology (Hybrid Congress)"-- Meeting was also presented virtually -- Source: Wos |
